Breast Cancer and Bone Loss

Cancer Treatment-Induced Bone Loss in women with breast cancer.

Osteoporosis is one of the most frequent diseases in postmenopausal women, leading to an increased fracture risk due to the physiologic loss of the bone protective effects of estrogen. Hereby, several risk factors for fracture such as prevalent fracture, low bone mineral density (BMD), age, low body mass index, family history, tendency to falls, smoking, use of SSRIs, glucocorticoid use etc. ha...

Breast Implants and Breast Cancer

Breast Cancer and Screening

سرطان پستان یکی از شایع ترین بیماریهای بدخیم و اولین علت مرگ و میر زنان بوده و تقریبا یک سوم تمام سرطانهای زنان را تشکیل می دهد.

Does adjuvant chemotherapy change bone mineral density and related serum biomarkers in women with breast cancer?

Background: The primary objective of this study was to assess BMD change in Iranian females with breast cancer. Methods: A sample of 73 female breast cancer patients treated with adjuvant chemotherapy either alone or followed by radiotherapy between March 2013 and February 2016 were considered for this study. Bone mineral density (BMD) change was evaluated by measuring z-score of lumbar spin...

Cancer treatment-induced bone loss in patients with breast or prostate cancer.

PURPOSE/OBJECTIVES To review the prevalence, consequences, pathophysiology, diagnosis, and treatment of cancer treatment-induced bone loss (CTIBL) in patients with breast or prostate cancer. DATA SOURCES Published articles, abstracts, book chapters, electronic resources, and manufacturer information. DATA SYNTHESIS CTIBL is a long-term complication associated with cancer therapies that caus...